XML 36 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flow from operating activities    
Net loss $ (8,599) $ (8,583)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 684 554
Amortization of technology license 0 161
Amortization of right of use assets 96 0
Depreciation 134 265
Impairment of technology license 0 608
(Increase) decrease in operating assets    
Prepaid drug product for testing (444) 785
Other current assets 15 (450)
Increase (decrease) in operating liabilities    
Accounts payable and accrued expenses (168) 536
Lease liabilities (79) 0
Net cash used in operating activities (8,361) (6,124)
Cash flow from investing activities    
Purchases of furniture, fixtures & equipment 0 (17)
Net cash used in investing activities 0 (17)
Cash flow from financing activities    
Net proceeds from sale of common stock 26,700 1,180
Net proceeds from exercise of warrants 1,083 0
Net cash provided by financing activities 27,783 1,180
Net increase (decrease) in cash 19,422 (4,961)
Cash, beginning of period 1,004 5,965
Cash, end of period 20,426 1,004
Non-cash investing activities    
Addition to leasehold improvements $ 31 $ 0